Trials / Withdrawn
WithdrawnNCT03933930
Comparing the Prognosis of Lactate-directed and Goal-directed Therapy in Hyperthermic Intraperitoneal Chemotherapy.
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Taipei Medical University WanFang Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Hyperthermic intraperitoneal chemotherapy is a major surgery for tumor peritoneal metastasis. For anesthesiologist, the intra-operative fluid control is always a big challenge. We try to compare the prognosis of lactate-directed and goal-directed therapy. We expect to confirm the better prognosis of lactate-directed therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Lactate-directed therapy | If the lactate level elevates, we transfuse pRBC to increase Hct\>30%. If Hct \>30%, dopamine infusion starts. |
| OTHER | Goal-directed therapy | If SVV\>15%, transfuse lactate ringer/normal saline alternatively to keep SVV\<15%. |
Timeline
- Start date
- 2019-05-06
- Primary completion
- 2021-05-15
- Completion
- 2021-05-15
- First posted
- 2019-05-01
- Last updated
- 2020-06-04
Source: ClinicalTrials.gov record NCT03933930. Inclusion in this directory is not an endorsement.